Nuclease Products

Highly efficient gene editing enzymes with extremely low off-target activity, as well as versatile nucleases widely used to eliminate nucleic acid residues in biological products, are crucial for ensuring the safety and effectiveness of gene therapy drugs. uBriGene can provide you with a variety of gene editing enzymes and universal nucleases developed and produced under GMP conditions to meet the diverse needs of scientific research and cell & gene therapy clients. uBriGene wholeheartedly supports our clients in various stages, including preclinical research, Investigational New Drug (IND) filing, clinical trials, Biologics License Application (BLA) submission, and eventual market listing. This commitment contributes significantly to the advancement of fundamental research and the development of the cell and gene therapy industry.